home / stock / cyto / cyto news

CYTO News and Press, Altamira Therapeutics Ltd.

Stock Information
Company Name: Altamira Therapeutics Ltd.
Stock Symbol: CYTO
Market: NASDAQ
Website: aurismedical.com
Menu
CYTO CYTO Quote CYTO Short CYTO News CYTO Articles CYTO Message Board
Get CYTO Alerts

News, Short Squeeze, Breakout and More Instantly...
CYTO - Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira’s SemaPhore™ nanoparticles delivering SOD2 mRNA successfully to...
CYTO - Expected US Company Earnings on Wednesday, July 10th, 2024

AZZ Inc. (AZZ) is expected to report $1.31 for Q1 2025 Express Inc. (EXPRQ) is expected to report for Q1 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2025 Altamira Therapeutics Ltd. (CYTO) is expected to report for Q1 2024 Bassett Furniture Industries Incorporated (...

CYTO - Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management

Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) patients Betahistine is markete...

CYTO - Sea, DraftKings, Sasol among premarket losers' pack

2024-05-28 08:48:33 ET Marpai ( MRAI ) -41% on notice of delisting or failure to satisfy a continued listing rule . OneMedNet ( ONMD ) -20% . Gold Royalty ( GROY ) -15% after agreeing to acquire a copper stream on the Vares silver project , oper...
CYTO - Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

2024-05-24 08:45:04 ET Palm Beach, FL – May 24, 2024 – The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic cancer, a particularly aggressive and often fatal form of ca...

CYTO - Jaguar Health, Altamira Therapeutics,Erasca among healthcare movers

2024-05-23 10:04:37 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

CYTO - Altamira stock soars 45% on Bentrio social media postings

2024-05-23 10:00:23 ET More on Altamira Therapeutics Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript Altamira reports publication of positive results from NASAR clinical tria...
CYTO - US Companies Moving the Markets, Morning edition
Thu, May 23, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...

CYTO - Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal

Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMIL TON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets bey...

CYTO - Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd. (“Altamira” or t...
Next 10